相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hematopoietic stem cells and progenitors of chronic myeloid leukemia express leukemia-associated antigens: implications for the graft-versus-leukemia effect and peptide vaccine-based immunotherapy
A. S. M. Yong et al.
LEUKEMIA (2008)
Tumor associated antigen PRAME is a marker of favorable prognosis in childhood acute myeloid leukemia patients and modifies the expression of S100A4, Hsp 27, p21, IL-8 and IGFBP-2 in vitro and in vivo
Nicolas Tajeddine et al.
LEUKEMIA & LYMPHOMA (2008)
Active FKHRL1 overcomes imatinib resistance in chronic myelogenous leukemia-derived cell lines via the production of tumor necrosis factor-related apoptosis-inducing ligand
Satoru Kikuchi et al.
CANCER SCIENCE (2007)
A functional genetic screen identifies retinoic acid signaling as a target of histone deacetylase inhibitors
Mirjam T. Epping et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
PRAME expression is not associated with down-regulation of retinoic acid signaling in primary acute myeloid leukemia
Daniel Steinbach et al.
CANCER GENETICS AND CYTOGENETICS (2007)
Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression
Nadarajah Vigneswaran et al.
BMC CANCER (2007)
Chronic myeloid leukaemia as a model of disease evolution in human cancer
Junia V. Melo et al.
NATURE REVIEWS CANCER (2007)
A causal role for the human tumor antigen preferentially expressed antigen of melanoma in cancer
Mirjam. T. Epping et al.
CANCER RESEARCH (2006)
PRAME is a membrane and cytoplasmic protein aberrantly expressed in chronic lymphocytic leukemia and mantle cell lymphoma
Rodrigo Proto-Siqueira et al.
LEUKEMIA RESEARCH (2006)
Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature
Keith S. Hoek et al.
PIGMENT CELL RESEARCH (2006)
Downregulation of TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L in Barrett's esophagus with dysplasia and adenocarcinoma
Nikolay K. Popnikolov et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2006)
Gene expression changes associated with progression and response in chronic myeloid leukemia
JP Radich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
X chromosomal abnormalities in basal-like human breast cancer
AL Richardson et al.
CANCER CELL (2006)
Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model
RS Stearman et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
The human tumor antigen repressor of retinoic acid PRAME is a dominant receptor signaling
MT Epping et al.
CELL (2005)
Expression of TRAIL and TRAIL receptors in normal and malignant tissues
RA Daniels et al.
CELL RESEARCH (2005)
The gene expression signatures of melanoma progression
C Haqq et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells
A Nebbioso et al.
NATURE MEDICINE (2005)
Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway
A Insinga et al.
NATURE MEDICINE (2005)
Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy
K Takeda et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL
N Clarke et al.
EMBO JOURNAL (2004)
The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome
A Oberthuer et al.
CLINICAL CANCER RESEARCH (2004)
ONCOMINE: A cancer microarray database and integrated data-mining platform
DR Rhodes et al.
NEOPLASIA (2004)
TRAIL and apoptosis induction by TNF-family death receptors
SL Wang et al.
ONCOGENE (2003)
Bcr-Abl-mediated resistance to apoptosis is independent of constant tyrosine-kinase activity
AEB Bueno-da-Silva et al.
CELL DEATH AND DIFFERENTIATION (2003)
TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome-positive leukemia cells
K Uno et al.
BLOOD (2003)
Comparison of the anti-apoptotic effects of Bcr-Abl, Bcl-2 and Bcl-XL following diverse apoptogenic stimuli
G Brumatti et al.
FEBS LETTERS (2003)
Myriadenolide, a labdane diterpene isolated from Alomia myriadenia (asteraceae) induces depolarization of mitochondrial membranes and apoptosis associate with activation of caspases-8, -9, and -3 in Jurkat and THP-1 cells
EM Souza-Fagundes et al.
EXPERIMENTAL CELL RESEARCH (2003)
T cells require TRAIL for optimal graft-versus-tumor activity
C Schmaltz et al.
NATURE MEDICINE (2002)
Gene-expression profiles predict survival of patients with lung adenocarcinoma
DG Beer et al.
NATURE MEDICINE (2002)
Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice
E Cretney et al.
JOURNAL OF IMMUNOLOGY (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development
K Takeda et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-γ-dependent suppression of subcutaneous tumor growth
K Takeda et al.
CELLULAR IMMUNOLOGY (2001)
Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL
L Altucci et al.
NATURE MEDICINE (2001)
Identification of a melanoma antigen, PRAME, as a BCR/ABL-inducible gene
K Watari et al.
FEBS LETTERS (2000)
分享论文
